Repeat dose opioids may be effective for breathlessness in chronic heart failure if given for long enough

Journal of Palliative Medicine

Volumn 16, Issue 3, 2013, Pages 250-255

  Oxberry, Stephen G ^a   Bland, J Martin ^b   Clark, Andrew L ^c   Cleland, John G ^c   Johnson, Miriam J ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

^c UNIVERSITY OF HULL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; MORPHINE SULFATE; OXYCODONE; PLACEBO;

ABDOMINAL CRAMP; AGED; ARTICLE; BORG SCORE; CLINICAL ARTICLE; CONTROLLED STUDY; COPING BEHAVIOR; CROSSOVER PROCEDURE; DIARRHEA; DISEASE SEVERITY; DISTRESS SYNDROME; DRUG EFFICACY; DRUG WITHDRAWAL; DYSPNEA; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LOW DRUG DOSE; MALE; OBSERVATIONAL STUDY; OPEN STUDY; PATIENT SATISFACTION; QUALITY OF LIFE; RATING SCALE; SCORING SYSTEM; SHORT FORM 12; SIDE EFFECT; TREATMENT DURATION; TREATMENT RESPONSE;

AGED; ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; CHRONIC DISEASE; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DYSPNEA; FEMALE; HEART FAILURE; HUMANS; MALE; MORPHINE; OXYCODONE; PLACEBOS; PRINCIPAL COMPONENT ANALYSIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84874452170     PISSN: 10966218     EISSN: 15577740     Source Type: Journal    
DOI: 10.1089/jpm.2012.0270     Document Type: Article

References (27)

1. Thomas S, Rich MW: Epidemiology, pathophysiology, and prognosis of heart failure in the elderly. Clin Geriatr Med 2007;23:1-10.
2. Piepoli M, Clark AL, Volterrani M, Adamopoulos S, Sleight P, Coats AJ: Contribution of muscle afferents to the hemodynamic, autonomic, and ventilatory responses to exercise in patients with chronic heart failure: Effects of physical training. Circulation 1996;93:940-952.
3. Francis GS: Neuroendocrine activity in congestive heart failure. Am J Cardiol 1990;66:33DY38D.
4. Fontana F, Bernardi P, Pich EM, Capelli M, Bortoluzzi L, Spampinato S, Canossa M: Relationship between plasma atrial natriuretic factor and opioid peptide levels in healthy subjects and in patients with acute congestive heart failure. Eur Heart J 1993;14:219-225.
5. Perna GP, Modoni S, Valle G, Stanislao M, Loperfido F: Plasma beta-endorphin response to exercise in patients with congestive heart failure. Chest 1997;111:19-22.
6. Wong TM, Shan J: Modulation of sympathetic actions on the heart by opioid receptor stimulation. J Biomed Sci 2001; 8:299-306.
7. Pepe S, van den Brink OWV, Lakatta EG, Xiao RP: Crosstalk of opioid peptide receptor and beta-adrenergic receptor signalling in the heart. Cardiovasc Res 2004;63:414-422.
8. Currow DC, McDonald C, Oaten S, Kenny B, Allcroft P, Frith P, Briffa M, Johnson MJ, Abernethy AP: Once daily opioids for chronic dyspnoea: A dose increment and pharmacovigilance study. J Pain Symptom Manage 2011;42: 388-399
9. Evangelista, LS, Sackett E, Dracup K: Pain and heart failure: Unrecognized and untreated. Eur J Cardiovasc Nurs 2009: 8:169-173.
10. Jennings AL, Davies AN, Higgins JP, Broadley K: Opioids for the palliation of breathlessness in terminal illness. Cochrane Database Syst Rev [Online] 2001;4:CD002066.
11. Abernethy AP, Currow DC, Frith P, Fazekas BS, Mc Hugh A, Bui C: Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ 2003;327:523-528.
12. Johnson MJ, McDonagh TA, Harkness A, McKay SE, Dargie HJ: Morphine for the relief of breathlessness in patients with chronic heart failure: A pilot study. Eur J Heart Fail 2002;4:753-756.
13. Oxberry SG, Torgerson DJ, Bland JM, Clark AL, Cleland JGF, Johnson MJ: Short-term opioids for breathlessness in stable chronic heart failure: A randomised controlled trial. Eur J Heart Fail 2011;13:106-112.
14. Ware JE, Konsinski M, Keller SD: SF-12: An even shorter health survey. Med Outcomes Trust Bull 1996;4:2.
15. Mor V, Laliberte L, Morris JN, Wiemann M: The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting. Cancer 1984;53: 2002-2007.
16. Borg G: A category scale with ratio properties for intermodal and interindividual comparisons.In: Geissler HG, Petzoldt G (eds): Psychophysical Judgements and the Process of Perception. Berlin: Deutscher Verlag, 1982.
17. Gift AG Narsavage G: Validity of the numeric rating scale as a measure of dyspnea. Am J Crit Care 1998;7:200-204.
18. Bausewein C, Farquhar M, Booth S, Gysels M, Higginson IJ: Measurement of breathlessness in advanced disease: A systematic review. Respir Med 2007;101:399-410.
19. Dorman S, Byrne A, Edwards A: Which measurement scales should we use to measure breathlessness in palliative care? A systematic review. Palliat Med 2007;21:177-191.
20. Dorman S, Jolley C, Abernethy AP, Currow DC, Johnson M, Farquhar M, Griffiths G, Peel T, Moosavi SH, Byrne A, Wilcock A, Alloway L, Bausewein C, Higginson IJ, Booth S: Researching breathlessness in palliative care: Consensus statement of the National Cancer Research Institute Palliative Care Breathlessness Subgroup. Palliat Med 2009;23:213-227.
21. Currow DC, Agar M, Smith J, Abernethy AP: Does palliative home oxygen improve dyspnoea? A consecutive cohort study. Palliat Med 2009;23:309-316.
22. Abernethy AP, McDonald C, Frith P, Clark K, Herndon JE, Marcello J, Young IH, Bull J, Wilcock A, Booth S, Wheeler JL, Tulsky JA, Crockett AJ, Currow DC: Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnea: A double-blind, randomized controlled trial. Lancet 2010;376:784-793.
23. Barton R, English A, Nabb S, Rigby AS, Johnson MJ: A randomised trial of high vs low intensity training in breathing techniques for breathless patients with malignant lung disease: A feasibility study. Lung Cancer 2010;70: 313-319.
24. Guyatt GH, Feeny DH, Patrick DL: Measuring health related quality of life. Ann Inter Med 1993;118:622-629.
25. Currow DC, Plummer J, Frith P, Abernethy AP: Can we predict which patients with refractory dyspnea will respond to opioids? J Palliat Med 2007;10:1031-1036.
26. Bredin M, Corner J, Krishnasamy M, Plant H, Bailey C, A'Hern R: Multicentre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer. BMJ 1999;318:901-904.
27. Johnson MJ, Abernethy AP, Currow DC: Gaps in the evidence base of opioids for refractory breathlessness: A future work plan? JPSM 2012;43:614-624.